QCM
EBS icon

Quantinno Capital Management’s Emergent Biosolutions EBS Stock Holding History

Quantinno Capital Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$376K Buy
44,843
+29,546
+193% +$247K ﹤0.01% 3119
2026
Q1 		$127K Buy
+15,297
New +$158K ﹤0.01% 3249

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Quantinno Capital Management's EBS Position: Q2 2026 in Review

Quantinno Capital Management increased its Emergent Biosolutions (EBS) stake by 193% in Q2 2026, buying an estimated $247K and bringing the position to 44,843 shares worth $376K. The position accounts for ﹤0.01% of the portfolio, ranked #3119.

Quantinno Capital Management first reported a position in EBS in Q1 2026 and has held it in 2 quarters since. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Quantinno Capital Management held 44,843 shares of Emergent Biosolutions worth $376K as of Q2 2026.
  • Quantinno Capital Management bought 29,546 Emergent Biosolutions shares in Q2 2026, an estimated $247K.
  • Emergent Biosolutions made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #3119 holding.
  • Quantinno Capital Management first reported a position in Emergent Biosolutions in Q1 2026 and has held it in 2 quarters since.
  • 194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.